CHF-6366
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
COA:
Inquire
Targets:
M3, MABA
Description:
CHF-6366 is a dual-acting antagonist of muscarinic acetylcholine receptor M3 and beta-2 adrenergic receptor (MABA) being developed as inhalable bronchodilator. Stusies in vivo and in vitro showed that CHF-6366 is a promising drug for the treatment of chronic obstructive pulmonary disease with long-acting, low toxic and potent activity.
Publictions citing BOC Sciences Products
  • >> More
Brife Description:
dual-acting antagonist of muscarinic acetylcholine receptor M3 and beta-2 adrenergic receptor (MABA)
MSDS:
Inquire
Application:
the potential treatment of chronic obstructive pulmonary disease
Current Developer:
Chiesi
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Quick Inquiry

Verification code

Featured Items